Topics

Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

02:00 EST 21 Feb 2019 | Sciad Newswire

Dublin, Ireland and Bournemouth, UK, 21st February 2019 / Sciad NewswireValitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announce a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines.

Original Article: Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

NEXT ARTICLE

More From BioPortfolio on "Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...